{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:17:32Z","timestamp":1774297052457,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,29]]},"DOI":"10.7759\/cureus.44310","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T10:13:58Z","timestamp":1693304038000},"source":"Crossref","is-referenced-by-count":4,"title":["Desmopressin as a Treatment in Patients With Von Willebrand Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Andres","family":"Beltran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo P","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Carolina","family":"Barberan Parraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Luis","family":"Guan\u00edn Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor G","family":"Gaibor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G","family":"Cueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek FW","year":"2016","unstructured":"Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med. 2016, 375:2067-80. 10.1056\/NEJMra1601561","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James PD","year":"2021","unstructured":"James PD, Connell NT, Ameer B, et al.. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021, 5:280-300. 10.1182\/bloodadvances.2020003265","journal-title":"Blood Adv"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.07.051","article-title":"How I treat von Willebrand disease","volume":"196","author":"Castaman G","year":"2020","unstructured":"Castaman G. How I treat von Willebrand disease. Thromb Res. 2020, 196:618-25. 10.1016\/j.thromres.2020.07.051","journal-title":"Thromb Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci PM","year":"1998","unstructured":"Mannucci PM. Hemostatic drugs. N Engl J Med. 1998, 339:245-53. 10.1056\/NEJM199807233390407","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12254","article-title":"Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders","volume":"20","author":"Leissinger C","year":"2014","unstructured":"Leissinger C, Carcao M, Gill JC, Journeycake J, Singleton T, Valentino L. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia. 2014, 20:158-67. 10.1111\/hae.12254","journal-title":"Haemophilia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman G","year":"2013","unstructured":"Castaman G, Goodeve A, Eikenboom J. Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica. 2013, 98:667-74. 10.3324\/haematol.2012.077263","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman G","year":"2008","unstructured":"Castaman G, Lethagen S, Federici AB, et al.. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood. 2008, 111:3531-9. 10.1182\/blood-2007-08-109231","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici AB","year":"2004","unstructured":"Federici AB, Mazurier C, Berntorp E, et al.. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood. 2004, 103:2032-8. 10.1182\/blood-2003-06-2072","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003620","article-title":"von Willebrand disease: proposing definitions for future research","volume":"5","author":"Connell NT","year":"2021","unstructured":"Connell NT, James PD, Brignardello-Petersen R, et al.. von Willebrand disease: proposing definitions for future research. Blood Adv. 2021, 5:565-9. 10.1182\/bloodadvances.2020003620","journal-title":"Blood Adv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2450\/2008.0035-08","article-title":"Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage","volume":"6","author":"Franchini M","year":"2008","unstructured":"Franchini M. Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage. Blood Transfus. 2008, 6:33-8. 10.2450\/2008.0035-08","journal-title":"Blood Transfus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14801","article-title":"Desmopressin (DDAVP) use in patients with von Willebrand disease: a single-centre retrospective review of test response and clinical outcomes","volume":"29","author":"Chandrakumaran P","year":"2023","unstructured":"Chandrakumaran P, Hews-Girard J, Poon MC. Desmopressin (DDAVP) use in patients with von Willebrand disease: a single-centre retrospective review of test response and clinical outcomes. Haemophilia. 2023, 29:1095-103. 10.1111\/hae.14801","journal-title":"Haemophilia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2020.19021","article-title":"Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery","volume":"31","author":"Wang LC","year":"2020","unstructured":"Wang LC, Hu YF, Chen L, Xing R, Lin XF, Kou QY. Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery. Turk J Gastroenterol. 2020, 31:474-81. 10.5152\/tjg.2020.19021","journal-title":"Turk J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S389241","article-title":"Von Willebrand disease epidemiology, burden of illness and management: a systematic review","volume":"14","author":"Du P","year":"2023","unstructured":"Du P, Bergamasco A, Moride Y, Truong Berthoz F, \u00d6zen G, Tzivelekis S. Von Willebrand disease epidemiology, burden of illness and management: a systematic review. J Blood Med. 2023, 14:189-208. 10.2147\/JBM.S389241","journal-title":"J Blood Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17855","article-title":"Investigation of the effects of intranasal desmopressin on the bleeding of the patients during open septorhinoplasty: a randomized double-blind clinical trial","volume":"9","author":"Akbarpour M","year":"2023","unstructured":"Akbarpour M, Jalali MM, Akbari M, Nasirmohtaram S, Haddadi S, Habibi AF, Azad F. Investigation of the effects of intranasal desmopressin on the bleeding of the patients during open septorhinoplasty: a randomized double-blind clinical trial. Heliyon. 2023, 9:e17855. 10.1016\/j.heliyon.2023.e17855","journal-title":"Heliyon"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/a-1476-7768","article-title":"Effect of DDAVP on platelet activation and platelet-derived microparticle generation","volume":"42","author":"Persyn M","year":"2022","unstructured":"Persyn M, Athanase N, Trossa\u00ebrt M, Sigaud M, Ternisien C, B\u00e9n\u00e9 MC, Fouassier M. Effect of DDAVP on platelet activation and platelet-derived microparticle generation. Hamostaseologie. 2022, 42:185-92. 10.1055\/a-1476-7768","journal-title":"Hamostaseologie"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005431","article-title":"Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis","volume":"6","author":"Kalot MA","year":"2022","unstructured":"Kalot MA, Husainat N, Abughanimeh O, et al.. Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis. Blood Adv. 2022, 6:3735-45. 10.1182\/bloodadvances.2021005431","journal-title":"Blood Adv"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049493","article-title":"Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study","volume":"12","author":"Heijdra JM","year":"2022","unstructured":"Heijdra JM, Al Arashi W, de Jager NC, et al.. Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study. BMJ Open. 2022, 12:e049493. 10.1136\/bmjopen-2021-049493","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.841","article-title":"Effect of desmopressin on bleeding during endoscopic sinus surgery: a randomized clinical trial","volume":"7","author":"Akbarpour M","year":"2022","unstructured":"Akbarpour M, Jalali MM, Akbari M, Haddadi S, Fani G. Effect of desmopressin on bleeding during endoscopic sinus surgery: a randomized clinical trial. Laryngoscope Investig Otolaryngol. 2022, 7:920-7. 10.1002\/lio2.841","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211064064","article-title":"Prophylactic management of patients with von Willebrand disease","volume":"12","author":"Franchini M","year":"2021","unstructured":"Franchini M, Seidizadeh O, Mannucci PM. Prophylactic management of patients with von Willebrand disease. Ther Adv Hematol. 2021, 12:20406207211064064. 10.1177\/20406207211064064","journal-title":"Ther Adv Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/adj.12813","article-title":"Inherited bleeding disorders in oral procedures. Assessment of prophylactic and therapeutic protocols: a scoping review","volume":"66","author":"de Azevedo Kinalski M","year":"2021","unstructured":"de Azevedo Kinalski M, Sarkis-Onofre R, Dos Santos MB. Inherited bleeding disorders in oral procedures. Assessment of prophylactic and therapeutic protocols: a scoping review. Aust Dent J. 2021, 66:150-8. 10.1111\/adj.12813","journal-title":"Aust Dent J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(95)00102-w","article-title":"Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity","volume":"79","author":"Horstman LL","year":"1995","unstructured":"Horstman LL, Valle-Riestra BJ, Jy W, Wang F, Mao W, Ahn YS. Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res. 1995, 79:163-74. 10.1016\/0049-3848(95)00102-w","journal-title":"Thromb Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12032","article-title":"Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin","volume":"19","author":"Trummer A","year":"2013","unstructured":"Trummer A, Haarmeijer B, Werwitzke S, Wermes C, Ganser A, Budde U, Tiede A. Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin. Haemophilia. 2013, 19:236-41. 10.1111\/hae.12032","journal-title":"Haemophilia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183247-desmopressin-as-a-treatment-in-patients-with-von-willebrand-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:43Z","timestamp":1707508543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183247-desmopressin-as-a-treatment-in-patients-with-von-willebrand-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.44310","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}